Literature DB >> 25222147

SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter.

Jennifer A Smith1, Friederike S Haberstroh1, Elizabeth A White1, David M Livingston2, James A DeCaprio3, Peter M Howley4.   

Abstract

An important step in the malignant progression of HPV-associated lesions is the dysregulation of expression of the viral E6 and E7 oncogenes. This is often achieved through the loss of expression of E2, which represses the HPV LCR promoter and E6/E7 expression. Our previous studies confirmed a role for Brd4 in mediating the E2 transcriptional repression function, and identified JARID1C/SMCX and EP400 as contributors to E2-mediated repression. Here we show that TIP60, a component of the TIP60/TRRAP histone acetyltransferase complex, also contributes to the E2 repression function, and we extend our studies on SMCX. Di- and tri-methyl marks on histone H3K4 are reduced in the presence of E2 and SMCX, suggesting a mechanism by which SMCX contributes to E2-mediated repression of the HPV LCR. Together, these findings lead us to hypothesize that E2 recruits histone-modifying cellular proteins to the HPV LCR, resulting in transcriptional repression of E6 and E7.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin; E2; EP400; H3K4; LCR; Methylation; Papillomavirus; SMCX; TIP60; Transcriptional repression

Mesh:

Substances:

Year:  2014        PMID: 25222147      PMCID: PMC4252969          DOI: 10.1016/j.virol.2014.08.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  Brd4 regulation of papillomavirus protein E2 stability.

Authors:  Gang Zheng; Michal-Ruth Schweiger; Gustavo Martinez-Noel; Leon Zheng; Jennifer A Smith; J Wade Harper; Peter M Howley
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

2.  Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming.

Authors:  Margaret E McLaughlin-Drubin; Christopher P Crum; Karl Münger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

3.  Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor.

Authors:  Pei-Ching Chang; Latricia D Fitzgerald; Datsun A Hsia; Yoshihiro Izumiya; Chun-Yi Wu; Wen-Ping Hsieh; Su-Fang Lin; Mel Campbell; Kit S Lam; Paul A Luciw; Clifford G Tepper; Hsing-Jien Kung
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  The SANT domain of p400 ATPase represses acetyltransferase activity and coactivator function of TIP60 in basal p21 gene expression.

Authors:  Jeong Hyeon Park; Xiao-Jian Sun; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

5.  Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.

Authors:  Sudhakar Jha; Scott Vande Pol; Nilam Sanjib Banerjee; Arun Brendan Dutta; Louise T Chow; Anindya Dutta
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

6.  Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.

Authors:  Justin M Reitsma; John Paul Savaryn; Katherine Faust; Hiromi Sato; Brian D Halligan; Scott S Terhune
Journal:  Cell Host Microbe       Date:  2011-02-17       Impact factor: 21.023

7.  The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.

Authors:  J A Anderton; S Bose; M Vockerodt; K Vrzalikova; W Wei; M Kuo; K Helin; J Christensen; M Rowe; P G Murray; C B Woodman
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

8.  Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.

Authors:  Jennifer A Smith; Elizabeth A White; Mathew E Sowa; Maria L C Powell; Matthias Ottinger; J Wade Harper; Peter M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

Review 9.  Papillomaviruses in the causation of human cancers - a brief historical account.

Authors:  Harald zur Hausen
Journal:  Virology       Date:  2009-01-08       Impact factor: 3.616

10.  Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Aarthi Narayanan; Hua Peng; Thomas M Kristie
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

View more
  16 in total

Review 1.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

2.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

Review 3.  Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives.

Authors:  Yicheng Mo; Jiabing Ma; Hongtao Zhang; Junjie Shen; Jun Chen; Juan Hong; Yanmin Xu; Cheng Qian
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

4.  Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.

Authors:  N Sanjib Banerjee; Dianne W Moore; Thomas R Broker; Louise T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

Review 5.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

Review 6.  Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin.

Authors:  Andrew Lopez; Randilea Nichols Doyle; Carina Sandoval; Karly Nisson; Vivian Yang; Oliver I Fregoso
Journal:  J Mol Biol       Date:  2021-10-22       Impact factor: 6.151

7.  Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.

Authors:  Ana Alfaro; Eligia Juárez-Torres; Ingrid Medina-Martínez; Norma Mateos-Guerrero; Maura Bautista-Huerta; Edgar Román-Bassaure; Nicolás Villegas-Sepúlveda; Jaime Berumen
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

8.  Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.

Authors:  Katharine E Dooley; Alix Warburton; Alison A McBride
Journal:  mBio       Date:  2016-09-13       Impact factor: 7.867

9.  HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.

Authors:  I J Groves; E L A Knight; Q Y Ang; C G Scarpini; N Coleman
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

10.  Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.

Authors:  Nicole V Anayannis; Nicolas F Schlecht; Miriam Ben-Dayan; Richard V Smith; Thomas J Belbin; Thomas J Ow; Duk M Blakaj; Robert D Burk; Sarah M Leonard; Ciaran B Woodman; Joanna L Parish; Michael B Prystowsky
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.